These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39455620)

  • 1. Bidirectional two-sample Mendelian randomization analysis unveils causal association between inflammatory cytokines and the risk of diabetic nephropathy.
    Song S; Yan Q; Yu J
    Sci Rep; 2024 Oct; 14(1):25425. PubMed ID: 39455620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal relationship between 731 immune cells and the risk of diabetic nephropathy: a two‑sample bidirectional Mendelian randomization study.
    Song S; Sun Y; Yu J
    Ren Fail; 2024 Dec; 46(2):2387208. PubMed ID: 39091101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The causal effect of inflammatory proteins and immune cell populations on diabetic nephropathy: evidence from Mendelian randomization.
    Ren Y; Zhang H
    Int Urol Nephrol; 2024 Aug; 56(8):2769-2778. PubMed ID: 38520496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between diabetic retinopathy and diabetic nephropathy: a two-sample Mendelian randomization study.
    Fang J; Luo C; Zhang D; He Q; Liu L
    Front Endocrinol (Lausanne); 2023; 14():1265711. PubMed ID: 38027162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal role of immune cells in diabetic nephropathy: a bidirectional Mendelian randomization study.
    Wang SY; Yu Y; Ge XL; Pan S
    Front Endocrinol (Lausanne); 2024; 15():1357642. PubMed ID: 39345891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between immune cells and diabetic nephropathy: a Mendelian randomization study.
    Li X; Zhang L; Yan C; Zeng H; Chen G; Qiu J
    Acta Diabetol; 2024 Oct; 61(10):1251-1258. PubMed ID: 38762618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the causal link between circulating cytokines and sarcopenia traits: A Mendelian randomization analysis.
    Di W; Luyao Y; Chengwei Y; Valtonen AM; Juha-Pekka K; Ying G
    Environ Toxicol; 2024 Jun; 39(6):3434-3447. PubMed ID: 38450985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the causal relationship between gut microbiota and diabetic nephropathy: insights from two-sample Mendelian randomization.
    Fang Y; Zhang Y; Liu Q; Zheng Z; Ren C; Zhang X
    Front Endocrinol (Lausanne); 2024; 15():1329954. PubMed ID: 38562415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causal relationships between systemic inflammatory cytokines and adhesive capsulitis: a bidirectional Mendelian randomization study.
    Ouyang Y; Dai M
    Front Immunol; 2024; 15():1380889. PubMed ID: 38979412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral adipose tissue and risk of diabetic nephropathy: A Mendelian randomization study.
    Tao M; Zhou G; Liu J; He M; Luo X; Wang C; Zhang L
    Diabetes Res Clin Pract; 2024 Mar; 209():111586. PubMed ID: 38364909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causal linkage between type 2 diabetes mellitus and inflammatory bowel disease: an integrated Mendelian randomization study and bioinformatics analysis.
    Xiao X; Wu X; Yi L; You F; Li X; Xiao C
    Front Endocrinol (Lausanne); 2024; 15():1275699. PubMed ID: 38313367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Mendelian randomization study investigating the causal relationships between inflammation and immunoglobulin A nephropathy.
    Ren Y; Zhang H
    Hum Immunol; 2024 Jul; 85(4):110830. PubMed ID: 38861759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coffee intake and risk of diabetic nephropathy: a Mendelian randomization study.
    Fang J; Song K; Zhang D; Liang Y; Zhao H; Jin J; He Q
    Front Endocrinol (Lausanne); 2023; 14():1169933. PubMed ID: 37469984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal association between vitamin D and diabetic neuropathy: a Mendelian randomization analysis.
    Huang W; Gu L; Wang J; Wang Y; Cao F; Jin T; Cheng Y
    Endocrine; 2023 May; 80(2):328-335. PubMed ID: 36754931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of inflammatory cytokines on the risk of hypertrophic scar: a mendelian randomization study.
    Qi S; Ma A; Lin H; Peng L; Deng E
    Arch Dermatol Res; 2024 Aug; 316(8):551. PubMed ID: 39167160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causal association of circulating cytokines with sarcopenia-related traits: A Mendelian randomization study.
    Chen J; Xinxin Z; Wang Z; Sun L; Tian Y
    Cytokine; 2024 Aug; 180():156643. PubMed ID: 38820838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causal effects of inflammatory bowel disease on risk of type 2 diabetes: a two-sample multivariable Mendelian randomization study.
    Niu Y; Zhang Q; Wei Y
    Acta Diabetol; 2024 Jun; 61(6):715-724. PubMed ID: 38427067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal association of circulating cytokines with sepsis: a Mendelian randomization study.
    Lin S; Mao X; He W
    Front Immunol; 2023; 14():1281845. PubMed ID: 37915587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A causal relationship between bone mineral density and breast cancer risk: a mendelian randomization study based on east Asian population.
    Cheng Z; Xu H; Wang X; Teng T; Li B; Cao Z; Li Z; Zhang J; Xuan J; Zhang F; Chen Y; Li Y; Wang W
    BMC Cancer; 2024 Sep; 24(1):1148. PubMed ID: 39277718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mendelian randomization suggests causal correlations between inflammatory cytokines and immune cells with mastitis.
    Chen J; Su B; Zhang X; Gao C; Ji Y; Xue X
    Front Immunol; 2024; 15():1409545. PubMed ID: 39399489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.